Accelerating future growth of medical ventures across Europe

Aescap Venture is a venture capital company which manages a portfolio of 8 private medical companies in Europe. Our portfolio consists of high-potential companies with realistic product opportunities. This involves companies in all phases of development and commercialisation.

Aescap Venture’s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.

Aescap is an acronym for ”Accelerating European Science Companies and Products” and derived from Aesculapius - the Greek god of healthcare - and capital.

The Fund is supported by the European Communities Growth and Employment Initiative, MAP - ETF Start up Facility.